András Guttman

Founder, Chief Technology Officer at BioSystems International SAS

András Guttman

András Guttman

Founder, Chief Technology Officer at BioSystems International SAS

Overview
Career Highlights

BioSystems International SAS

RelSci Relationships

65

Number of Boards

2

Relationships
RelSci Relationships are individuals András Guttman likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Scientific Advisor & Board Observer at BioAnalytix, Inc.

Relationship likelihood: Strong

Former President & Chief Scientific Officer at BioSystems International SAS

Relationship likelihood: Strong

Vice President, Manufacturing at Alnylam Pharmaceuticals, Inc.

Relationship likelihood: Strong

Former President at Casss

Relationship likelihood: Strong

Director at Casss

Relationship likelihood: Strong

Treasurer at Casss

Relationship likelihood: Strong

Director at Casss

Relationship likelihood: Strong

Former Director at Casss

Relationship likelihood: Strong

Director at Casss

Relationship likelihood: Strong

Director at Casss

Relationship likelihood: Strong

Paths to András Guttman
Potential Connections via
Relationship Science
You
András Guttman
Founder, Chief Technology Officer at BioSystems International SAS
Education
Ph.D Unknown

University of Pannonia is a school.

Career History
Founder, Chief Technology Officer
2004 - 2014

Biosystems International is a biotechnology company engaged in protein biomarker R&D using a unique and proprietary monoclonal antibody based proteomics technology (mAb proteomics), leading to the development of: Novel blood-based diagnostics for cancer and chronic diseases through the use of its innovative mAb proteomics approach, BSI is poised to translate its discoveries into novel blood-based diagnostics products for the early detection of cancer, a number of chronic diseases, and cancer recurrence with its most advanced program in the area of lung cancer currently under development.

Professional
Prior

Diversa searches high and low for DNA. In its quest to develop new enzymes and other active biological compounds, the biotechnology company collects and catalogs the DNA of organisms in diverse environments (from manure piles to tropical islands). A variety of manufacturers license these compounds from the firm to develop or improve their products, which include detergents, oils, animal feeds, and pharmaceuticals. Diversa's products include enzymes for the oil and gas industry

Professional
Prior

Torrey Mesa Research Institute develops genomic tools and gene technology. The company is headquartered in Fortitude San Diego, CA.

Boards & Committees
Member, Scientific Advisory Board
Prior

Biosystems International is a biotechnology company engaged in protein biomarker R&D using a unique and proprietary monoclonal antibody based proteomics technology (mAb proteomics), leading to the development of: Novel blood-based diagnostics for cancer and chronic diseases through the use of its innovative mAb proteomics approach, BSI is poised to translate its discoveries into novel blood-based diagnostics products for the early detection of cancer, a number of chronic diseases, and cancer recurrence with its most advanced program in the area of lung cancer currently under development.

Director
Tenure Unconfirmed

CASSS FACILITATES INTERACTION AMONG INDUSTRY, ACADEMIC & REGULATORY PROFESSIONALS (CONT. SCH. O) TO RESOLVE SCIENTIFIC CHALLENGES IN BIOPHARMACEUTICAL DEVELOPMENT & REGULATION.

Investments
Details Hidden

Biosystems International is a biotechnology company engaged in protein biomarker R&D using a unique and proprietary monoclonal antibody based proteomics technology (mAb proteomics), leading to the development of: Novel blood-based diagnostics for cancer and chronic diseases through the use of its innovative mAb proteomics approach, BSI is poised to translate its discoveries into novel blood-based diagnostics products for the early detection of cancer, a number of chronic diseases, and cancer recurrence with its most advanced program in the area of lung cancer currently under development.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by András Guttman. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of András Guttman's profile does not indicate a business or promotional relationship of any kind between RelSci and András Guttman.